Gratus Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $294K | Sell |
|
|||||
|
2024
Q1 | $399K | Buy |
|
|||||
|
2023
Q4 | $349K | Sell |
|
|||||
|
2023
Q3 | $423K | Buy |
|
|||||
|
2023
Q2 | $434K | Buy |
|
|||||
|
2023
Q1 | $457K | Sell |
|
|||||
|
2022
Q4 | $973K | Sell |
|
|||||
|
2022
Q3 | $993K | Buy |
|
|||||
|
2022
Q2 | $510K | Buy |
|
|||||
|
2022
Q1 | $411K | Sell |
|
|||||
|
2021
Q4 | $363K | Sell |
|
|||||
|
2021
Q3 | $384K | Buy |
|
|||||
|
2021
Q2 | $413K | Sell |
|
|||||
|
2021
Q1 | $393K | Sell |
|
|||||
|
2020
Q4 | $413K | Sell |
|
|||||
|
2020
Q3 | $439K | Sell |
|
|||||
|
2020
Q2 | $529K | Buy |
|
|||||
|
2020
Q1 | $451K | Sell |
|
|||||
|
2019
Q4 | $522K | Sell |
|
|||||
|
2019
Q3 | $416K | Sell |
|
|||||
|
2019
Q2 | $406K | Sell |
|
|||||
|
2019
Q1 | $833K | Sell |
|
|||||
|
2018
Q4 | $923K | Sell |
|
|||||
|
2018
Q3 | $1.13M | Sell |
|
|||||
|
2018
Q2 | $1.05M | Sell |
|
|||||
|
2018
Q1 | $1.21M | Buy |
|
|||||
|
2017
Q4 | $1.17M | Sell |
|
|||||
|
2017
Q3 | $1.24M | Sell |
|
|||||
|
2017
Q2 | $1.09M | Buy |
|
|||||
|
2017
Q1 | $1.05M | Buy |
|
|||||
|
2016
Q4 | $1.12M | Buy |
|
|||||
|
2016
Q3 | $1.02M | Buy |
|
|||||
|
2016
Q2 | $1.37M | Buy |
|